A thought provoking manuscript addressing key challenges facing the industry.
Nashville, TN (PRWEB) September 8, 2008 -- From pioneering research and profound insight into the inner workings of disease management (DM) comes a thought provoking manuscript addressing key challenges facing the industry. The article is published this month in The Journal of Managed Care Pharmacy.
http://www.amcp.org/data/jmcp/643-649_8055-Final.pdf [Why 2008 May Be The Tipping Point for Disease Management], by disease management research expert Brenda Motheral, BPharm, MBA, PhD, presents a compelling view on why 2008 has been a year of discontent in the disease management industry but could actually pave the way for new business models and competitors.
In the paper, Dr. Motheral explains: "While once the darling of employers and benefit consultants, disease management is now the object of considerable dissatisfaction and growing distrust. Based on industry observation, there seem to be multiple reasons for this disaffection, five of which include lack of: 1) alignment of vendor and client interests, 2) transparency in business arrangements; 3) plausibility in reports of financial and clinical outcomes; 4) rigorous evaluation methodology; and 5) convincing evidence of outcomes improvement."
The goal of this candid commentary is to draw attention to the DM industry's deficiencies while clearly stating that there are short- and long-term solutions to be considered. Here are a few examples outlined in the paper:
Led by Dr. Brenda Motheral, CareScientific is a trusted consulting resource developed to improve the efficiency and effectiveness of disease management, health, wellness and pharmaceutical care programs. To learn more, please visit www.CareScientific.com.
Marketing Communications Consultant
kate @ itstheagency.com
# # #
Read the full story at http://www.prweb.com/releases/2008/09/prweb1303304.htm
Copyright©2008 Vocus, Inc.
All rights reserved